Cyclosporin A improves the hyperosmotic response in an experimental dry eye model by inhibiting the HMGB1/TLR4/NF-κB signaling pathway
- 16 February 2023
- journal article
- research article
- Published by Elsevier in Experimental Eye Research
- Vol. 229, 109418
Abstract
No abstract availableKeywords
Funding Information
- Yantai Science and Technology Bureau
This publication has 42 references indexed in Scilit:
- Need for Animal Models of Meibomian Gland DysfunctionOphthalmology and Therapy, 2016
- TLR4-mediated inflammation is a key pathogenic event leading to kidney damage and fibrosis in cyclosporine nephrotoxicityArchives of Toxicology, 2016
- The protective effect of neutralizing high-mobility group box1 against chronic cyclosporine nephrotoxicity in miceTransplant Immunology, 2016
- High-mobility group Box-1 is involved in NMDA-induced retinal injury the in rat retinaExperimental Eye Research, 2015
- Amniotic membrane extract ameliorates benzalkonium chloride-induced dry eye in a murine modelExperimental Eye Research, 2013
- Cyclosporine and tacrolimus have inhibitory effects on toll-like receptor signaling after liver transplantationLiver Transplantation, 2013
- Mitochondrial Permeability Transition Pore in Inflammatory Apoptosis of Human Conjunctival Epithelial Cells and T Cells: Effect of Cyclosporin AInvestigative Ophthalmology & Visual Science, 2013
- Immunosuppressant cytoprotection correlates with HMGB1 suppression in primary astrocyte cultures exposed to combined oxygen-glucose deprivationPharmacological Reports, 2011
- An Objective Approach to Dry Eye Disease SeverityInvestigative Ophthalmology & Visual Science, 2010
- Human RPE-monocyte co-culture induces chemokine gene expression through activation of MAPK and NIK cascadeExperimental Eye Research, 2003